Where does Rennovia Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Rennovia Inc. ranks #16,310 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Rennovia Inc. hold?

Rennovia Inc. holds 18 US utility patents granted between 2015 and 2017, spanning 9 technology areas.

What is Rennovia Inc.'s Innovation Score?

Rennovia Inc. has an Innovation Score of 35.8 out of 100 (top 48% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Rennovia Inc. focus on?

Rennovia Inc.'s top technology area is C07C (Acyclic OR Carbocyclic Compounds) with 16 patents, ranking #281 of 2,691 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Rennovia Inc.'s patent grant rate increasing or decreasing?

Rennovia Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Rennovia Inc.'s patents?

Rennovia Inc.'s patents average 37.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Rennovia Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Rennovia Inc.

USPTO PatentsView assignee record - 18 granted patents across 9 technology areas, recorded in grant years 2015–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Rennovia ranks #16,310 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 9 technology areas.

#16,310
of 49,997 US assignees by volume: Top 48%
by Innovation Score (35.8/100): 37.4
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16310 · US Corporation #16,310 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 18 grants
MID-PACK #16,310/49,997
PHOTO-FINISH Recovery Force
CPC-NARROW C07C · 9 areas
INNOV-THIN 35.8/100
CLAIMS-DENSE 37.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Recovery Force, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rennovia’s 35.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.2 pts (28%) Velocity 0.0 pts (0%) Breadth 10.6 pts (30%) Claim depth 15.0 pts (42%)

Qualcomm Incorporated · highest

85
Rennovia · this assignee

36
3D Lighting… · lowest

7

What this shows Rennovia's Innovation Score is 35.8/100 (top 48% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Rennovia?

Each dot is one of Rennovia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rennovia’s own 37.4 claims/patent is ABOVE the 13.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Rennovia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rennovia's grants concentrate

Rennovia Inc. is a focused PatentsView assignee: 9 CPC subclasses with 88.9% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). Peak complete grant year is 2015 (8 grants) versus a trough of 3 in 2016. By volume, Rennovia sits between RTM Vital Signs LLC and Rhythmia Medical Inc..

RTM Vital Signs

18
Ruizhang Technolo…

18
Recovery Force

18
Redcritter

18
Research

18
Rheem Australia P…

18
Rheon Automatic M…

18
Rhythmia Medical

18
Rennovia ◀

18

What this shows Rennovia holds 18 patents at rank #16,312, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Rennovia

By rank, the assignees closest to #16,312 in granted patent volume.

Leaders in C07C (Acyclic OR Carbocyclic Compounds)

Other assignees with the most granted patents in Rennovia's primary technology class.

Rennovia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 48% higher than 52% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2017

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Rennovia Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	8	44.4%
2016	3	16.7%
2017	7	38.9%

Which technologies does Rennovia Inc. patent most?

C07C - Acyclic OR Carbocyclic Compounds 16

C07D - Heterocyclic Compounds 11

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 8

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 7

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 5

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 4

B01D - Separation 3

C04B - Lime, MAGNESIA; SLAG; CEMENTS; Compositions Thereof, e.g. Mortars, Concrete OR Like Building MATERIALS; Artificial Stone ; Ceramics ; REFRACTORIES; Treatment OF Natural Stone 1

C09C - Treatment OF Inorganic Materials, Other Than Fibrous Fillers, TO Enhance Their Pigmenting OR Filling Properties ; Preparation OF Carbon Black ; ; Preparation OF Inorganic Materials Which ARE NO Single Chemical Compounds AND Which ARE Mainly Used AS Pigments OR Fillers 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Rennovia Inc.'s patent record in context - here's where to go next.

Rennovia Inc.'s lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 88.9% of its portfolio - see every assignee active in that class. Explore C07C
Ranked #16,310 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Rennovia Inc. against RTM Vital Signs LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.